Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Short Communication Volume 7 Issue 4

Osteoporosis and Melatonin Hormone

Bushra Khairuddin Abdulqader*

Department of Medical Physiology, College of Medicine, University of Mosul, Mosul, Iraq

*Corresponding Author: Bushra Khairuddin Abdulqader, Department of Medical Physiology, College of Medicine, University of Mosul, Mosul, Iraq.

Received: February 21, 2023; Published: March 07, 2023

Osteoporosis (OP), the most prevalent bone disease, is a significant global public health issue. It is of three different forms: post-menopausal OP, which is mostly caused by decreased estrogen; senile OP, which is primarily caused by aging; and secondary OP, which is brought on by illnesses or medications [1].

References

  1. Patel Anish., et al. “Melatonin in neuroskeletal biology”. Current Opinion in Pharmacology 61 (2021): 42-48.
  2. Zheng Sheng., et al. “Melatonin Accelerates Osteoporotic Bone Defect Repair by Promoting Osteogenesis-Angiogenesis Coupling”. Frontiers in Endocrinology 13 (2022):
  3. Meng Xiao., et al. “Dietary Sources and Bioactivities of Melatonin”. Nutrients4 (2017): 367.
  4. Cipolla-Neto José and Fernanda Gaspar do Amaral. “Melatonin as a Hormone: New Physiological and Clinical Insights”. Endocrine Reviews6 (2018): 990-1028.
  5. Amaral Fernanda Gaspar do and José Cipolla-Neto. “A brief review about melatonin, a pineal hormone”. Archives of Endocrinology and Metabolism4 (2018): 472-479.
  6. Guan Huanshuai., et al. “Melatonin increases bone mass in normal, perimenopausal, and postmenopausal osteoporotic rats via the promotion of osteogenesis”. Journal of Translational Medicine1 (2022): 132.
  7. Egermann Marcus., et al. “Pinealectomy affects bone mineral density and structure--an experimental study in sheep”. BMC Musculoskeletal Disorders 12 (2011):
  8. Lu Xiaofeng., et al. “Insight into the roles of melatonin in bone tissue and bone‑related diseases (Review)”. International Journal of Molecular Medicine5 (2021): 82.
  9. Munmun Fahima and Paula A Witt-Enderby. “Melatonin effects on bone: Implications for use as a therapy for managing bone loss”. Journal of Pineal Research1 (2021): e12749.
  10. Zhang Jun., et al. “Melatonin restores osteoporosis-impaired osteogenic potential of bone marrow mesenchymal stem cells and alleviates bone loss through the HGF/PTEN/Wnt/β-catenin axis”. Therapeutic Advances in Chronic Disease 12 (2021):

Citation

Citation: Bushra Khairuddin Abdulqader. “Osteoporosis and Melatonin Hormone”.Acta Scientific Medical Sciences 7.4 (2023): 49-50.

Copyright

Copyright: © 2022 Bushra Khairuddin Abdulqader. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US